Drugs News and Research

RSS

John Theurer Cancer Center to present results of 31 studies at ASH 2011 meeting

The John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's top 50 best hospitals for cancer, will present research updates and clinical trial results of 31 cutting-edge studies at the 2011 American Society of Hematology (ASH) Annual Meeting in San Diego from December 10-13.

2 Dec 2011

Scottsdale resident donates $1 million to TGen pancreatic cancer initiative

A son's passion to find a cure for the cancer that claimed the life of his mother has led to a new series of clinical trials under a Translational Genomics Research Institute (TGen) initiative to find a cure for pancreatic cancer.

2 Dec 2011

First results from whole-genome sequencing clinical trial on triple negative breast cancer

Triple negative breast tumors, which make up nearly 20 percent of breast cancers, do not respond to treatment with targeted therapies such as Herceptin-(trastuzumab).

2 Dec 2011

New method reveals complete set of aberrant signaling pathways that give rise to cancers

One major obstacle in the fight against cancer is that anticancer drugs often affect normal cells in addition to tumor cells, resulting in significant side effects. Yet research into development of less harmful treatments geared toward the targeting of specific cancer-causing mechanisms is hampered by lack of knowledge of the molecular pathways that drive cancers in individual patients.

2 Dec 2011

World AIDS Day marks progress, but much work remains

News reports detail emerging strategies to prevent infection, but also examine lagging treatments and the populations that continue to have the highest incidence rates.

2 Dec 2011

The Lipitor story: Drug companies brace for losses as patents expire on this and other popular medications

News outlets analyze the impact that generic Lipitor could have on costs and the "era of 'blockbuster drugs'" as well as the strategies from Lipitor's maker to block its generic competitors. Meanwhile, some of these generics are already reaching the marketplace.

2 Dec 2011

Novelos prices underwritten public offering of $5,904,000 of common stock

Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced the pricing of an underwritten public offering of 9,840,000 units at $0.60 per unit for gross proceeds of $5,904,000.

2 Dec 2011

Cheaper test as effective as a more sophisticated test in guiding anti-retroviral drug treatment

A cheaper laboratory test that helps guide anti-retroviral drug treatment for people with HIV/AIDS may be just as effective as a more sophisticated test, a group of international researchers has found - a discovery that could be particularly important in rural Africa.

2 Dec 2011

Positive interim data from Anthera's PEARL-SC phase 2b clinical study in systemic lupus erythematosus

Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced positive interim biomarker data from the PEARL-SC phase 2b clinical study in patients with systemic lupus erythematosus.

1 Dec 2011

Government inspectors to lawmakers: More must be done to stop prescription of powerful psych drugs to nursing home patients

Government inspectors told lawmakers Wednesday that Medicare officials need to do more to stop doctors from prescribing powerful psychiatric drugs to nursing home patients with dementia, an unapproved practice that has flourished despite repeated government warnings.

1 Dec 2011

First Edition: December 1, 2011

In today's headlines, Republicans in Congress advance plan to charge wealthy beneficiaries more for Medicare in order to cover the costs of the proposaed payroll tax extension.

1 Dec 2011

House Committee expected to vote Wednesday to repeal CLASS Act

The Energy and Commerce Committee is expected to approve, along party lines, a measure to repeal the long-term care insurance program. Meanwhile, Sen. Sheldon Whitehouse, D-R.I., is being pressed to lift his hold on legislation to fund children's hospitals. He has been blocking the measure's progress because he still hopes to add an amendment that would expand it to children's psychiatric hospitals.

1 Dec 2011

Majority of Californians requiring mental health treatment receive inadequate services

Nearly 2 million adults in California, about 8 percent of the population, need mental health treatment, but the majority receive no services or inadequate services, despite a state law mandating that health insurance providers include mental health treatment in their coverage options, a new report by the UCLA Center for Health Policy Research shows.

1 Dec 2011

Compugen's Antibody Target Discovery Platform presented at 7th Annual European Antibody Congress

Speaking today at the plenary session of the 7th Annual European Antibody Congress in Geneva, Dr. Anat Cohen-Dayag, President and CEO of Compugen Ltd., presented Compugen's Antibody Target Discovery Platform, one of the Company's predictive discovery platforms for novel therapeutic targets.

1 Dec 2011

Santaris Pharma wins two LNA patent re-examination cases in the U.S.

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has won two significant patent re-examination cases brought by Isis Pharmaceuticals.

1 Dec 2011

Harvard SEAS, BASF to co-host symposium on pharmaceutical nanoformulations

From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.

1 Dec 2011

Potential test to diagnose membranous nephropathy in early stages

Research conducted by a pair of physicians at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) has led to the development of a test that can help diagnose membranous nephropathy in its early stages.

1 Dec 2011

Researchers identify first gene associated with frequent herpes-related cold sores

A team of researchers from the University of Utah and the University of Massachusetts has identified the first gene associated with frequent herpes-related cold sores.

1 Dec 2011

Neuropharmacology to publish Nutra Pharma's Alpha-Cobratoxin mechanism study on chronic pain

Nutra Pharma Corporation, a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that the journal Neuropharmacology will be publishing a mechanism study on the use of Alpha-Cobratoxin, a component of cobra venom, as a treatment for pain.

1 Dec 2011

Scripps scientist receives NIH grant for HIV/AIDS research

A scientist at The Scripps Research Institute has been awarded $3.4 million from the National Institutes of Health to study the mode of action and the therapeutic potential of a new compound that blocks a step of HIV replication not targeted by current therapies.

1 Dec 2011

Drugs News and Research

John Theurer Cancer Center to present results of 31 studies at ASH 2011 meeting

Scottsdale resident donates $1 million to TGen pancreatic cancer initiative

First results from whole-genome sequencing clinical trial on triple negative breast cancer

New method reveals complete set of aberrant signaling pathways that give rise to cancers

World AIDS Day marks progress, but much work remains

The Lipitor story: Drug companies brace for losses as patents expire on this and other popular medications

Novelos prices underwritten public offering of $5,904,000 of common stock

Cheaper test as effective as a more sophisticated test in guiding anti-retroviral drug treatment

Positive interim data from Anthera's PEARL-SC phase 2b clinical study in systemic lupus erythematosus

Government inspectors to lawmakers: More must be done to stop prescription of powerful psych drugs to nursing home patients

First Edition: December 1, 2011

House Committee expected to vote Wednesday to repeal CLASS Act

Majority of Californians requiring mental health treatment receive inadequate services

Compugen's Antibody Target Discovery Platform presented at 7th Annual European Antibody Congress

Santaris Pharma wins two LNA patent re-examination cases in the U.S.

Harvard SEAS, BASF to co-host symposium on pharmaceutical nanoformulations

Potential test to diagnose membranous nephropathy in early stages

Researchers identify first gene associated with frequent herpes-related cold sores

Neuropharmacology to publish Nutra Pharma's Alpha-Cobratoxin mechanism study on chronic pain

Scripps scientist receives NIH grant for HIV/AIDS research

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News